Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 129,594 |
|
|||||
| News | - | ||||||
| Day High | 9.16 | Low High |
|||||
| Day Low | 8.8401 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0065 | 0.07% | 9.0565 | 12:30:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.10 | 8.8401 | 9.16 | 9.05 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,025 | 129,594 | $ 9.03 | $ 1,169,994 | - | 2.86 - 11.41 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:30:30 | 115 | $ 9.0565 | USD |
Verrica Parmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 383.46M | 42.42M | - | 5.12M | -67M | -1.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Verrica Parmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.97 | 9.6747 | 8.45 | 8.84 | 182,927 | 0.0865 | 0.96% |
| 1 Month | 6.88 | 11.41 | 6.54 | 8.21 | 282,442 | 2.18 | 31.64% |
| 3 Months | 5.86 | 11.41 | 4.60 | 7.11 | 195,180 | 3.20 | 54.55% |
| 6 Months | 3.66 | 11.41 | 3.53 | 6.19 | 653,800 | 5.40 | 147.45% |
| 1 Year | 5.84 | 11.41 | 2.86 | 5.86 | 471,868 | 3.22 | 55.08% |
| 3 Years | 11.40 | 14.789 | 1.77 | 5.68 | 269,373 | -2.34 | -20.56% |
| 5 Years | 8.64 | 18.67 | 1.77 | 6.71 | 197,070 | 0.4165 | 4.82% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. |
